This surgery has the additional advantage of reducing the risk of breast cancer by up to 50% according to some studies [26,27], although risk reduction was not found in BRCA1 mutation carriers, nor in BRCA2 mutation carriers who had undergone this surgery within the previous five years in [28]. The gene discussed is BRCA2; the disease is breast carcinoma.